Viking Therapeutics's obesity/diabetes candidates and strong financials position it for success. Read here for an investment ...

Regeneron Pharmaceuticals sees strength in Dupixent, oncology gains, and major buybacks despite setbacks. Find out why REGN ...

SRMIST has announced the SRMJEEE 2025 phase 3 results, accessible on srmist.edu.in. Candidates can log in with their ...